| Biotechnology Industry | Healthcare Sector | Mr. Kunal Narendra Gandhi CEO | XNSE Exchange | INE933A01014 ISIN |
| IN Country | 296 Employees | - Last Dividend | - Last Split | - IPO Date |
Lyka Labs Limited is a prominent player in the pharmaceutical industry situated in Mumbai, India. Since its inception in 1976, the company has been dedicated to the development, manufacturing, and marketing of a wide array of pharmaceutical formulations and active pharmaceutical ingredients. It serves a diverse range of therapeutic segments, establishing a significant presence both domestically in India and in international markets. Lyka Labs stands out not only for its comprehensive product lineup but also for its contracted manufacturing services, which cater to the demands of large pharmaceutical companies. By providing medical and technical assistance, including manufacturing know-how, stability testing data, and clinical study data, the company has positioned itself as a go-to partner for pharmaceutical innovations and solutions.
Lyka Labs Limited offers a versatile range of products and services that cater to various medical and cosmetic needs:
The company's dedication to innovation is evident in its extensive product portfolio, which includes dermatological formulations, pain killers, anti-aging treatments, hair care solutions, and cosmeceuticals among others. Each product is developed with a focus on efficacy, safety, and quality, helping Lyka Labs to maintain its reputation as a trusted name in the pharmaceutical industry.